![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
One of their significant offerings is Nadolol, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-209 - Rev 02
This Chemical Type CEP, issued on July 16, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1789 associated with this CEP further emphasizes